Home > Products > Antibodies > Biosimilars

Research Grade Imsidolimab (HV577026)

Price(USD): $

Spec:

100ug
1mg

Number:

Contact us

Overview
Images
References
Datasheet

Overview

Catalog No.	HV577026
Species reactivity	Human
Applications	Research Grade Biosimilar
Host species	Humanized
Isotype	IgG4-Kappa
Expression system	Mammalian Cells
Clonality	Monoclonal
Target	FIL1D, Interleukin-1 family member 5, IL-36Ra, IL1HY1, Interleukin-36 receptor antagonist protein, IL1RP3, IL-1RP3, IL-1ra homolog 1, Interleukin-1-like protein 1, IL-1-related protein 3, IL1L1, Interleukin-1 HY1, IL-1HY1, Interleukin-1 delta, FIL1 delta, IL-1 delta, IL-1L1, Interleukin-1 receptor antagonist homolog 1, IL36RN, IL1F5, IL-1F5
Concentration	1mg/ml
Endotoxin level	Please contact the lab for this information.
Purity	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G, purified from cell culture supernatant.
Accession	Q9UBH0
Form	Liquid
Storage buffer	0.01M PBS,pH7.4.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -693°C.
Alternate Names	ANB-019,CAS:2102543-86-0
Background	Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases.
Note	For research use only. Not for use in clinical or therapeutic applications.

Images

Bioactivity

SEC-HPLC detection for Research Grade Imsidolimab.

References

Datasheet

Research Grade Imsidolimab.pdf

Recommendation

Research Grade Imsidolimab